Implantation of a cardiac pacemaker to circumvent complete heart block in a life-threatening hemangioma to allow the use of propranolol
| Autor: | Hashem Faqeeh, Sultan Al-Khenaizan |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Heart block medicine.medical_treatment Case Report infantile hemangioma Dermatology Propranolol Cardiac pacemaker SLE systemic lupus erythematosus Hemangioma CP cardiac pacemaker 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Internal medicine Infantile hemangioma medicine propranolol IH infantile hemangioma business.industry Cosmesis CCHB congenital complete heart block medicine.disease Congenital complete heart block 030220 oncology & carcinogenesis Cardiology business Airway cardiac pacemaker medicine.drug |
| Zdroj: | JAAD Case Reports |
| ISSN: | 2352-5126 |
| DOI: | 10.1016/j.jdcr.2019.06.029 |
| Popis: | Infantile hemangioma (IH) is the most common tumor of infancy, affecting up to 4% of infants with 40% requiring treatment because of cosmesis or compromise to vital structures or function, such as airway or vision.1, 2 Approved by the US Food and Drug Administration in 2014, propranolol is now considered the treatment of choice for complicated IHs and practically replaced all historic treatments like systemic steroids.3 Here we report a on preterm boy born with life-threatening parotid IH and congenital complete heart block (CCHB) owing to maternal systemic lupus erythematosus (SLE) who was treated successfully with propranolol after implantation of a cardiac pacemaker (CP). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|